FDA Investigator Sereen Gmorgan Murray
Sereen Gmorgan Murray has inspections in 4 countries as of 21 Jul 2023. Sereen Gmorgan Murray has collaborated with a combinined 899 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
71
Last Inspection Date:
21 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
New Zealand,
Hungary
Co-Investigator(s):
Alan R Moore,
Ann B Borromeo,
Anne E Johnson,
Anthony S Puckett,
April R Bowen,
Arlyss M Jones,
Barbara M Frazier,
Betsy C Galliher,
Bonita S Chester,
Brandy D Brown,
Cheryl A Grandinetti,
Claudele S Razo,
Contractor Bridgers,
Craig A Garmendia,
Cynthia F Kleppinger, MD,
David T Glover,
Derek C Price,
Devaughn Edwards,
Dr. Koffi A Amegadje,
Edward Deberry,
Eileen J Bannerman,
Ernest H Blackwood,
Ingrid A Zambrana,
Jackie M Douglas,
Jawaid Hamid,
John D Lloyd,
Joseph F Owens,
Karen M Cooper,
Kassa Ayalew, MD,
Kent A Conforti,
Lareese K Thomas,
Laura L Staples,
Lawrence,
Lawrence Thomas,
Leah M Andrews,
Leon L Crawley,
Matthew R Coleman,
Michelle D Haamid,
Michelle M Noe Varga,
Myla D Chapman,
N'jere English,
Nicole M Bell,
Patricia S Smith,
Sandra I Gaul,
Sheri S Oliver,
State Agency,
Stephanie E Hubbard,
Tracy R Ball,
Tyrico K English,
Vanessa E Coulter,
Viviana Matta,
William P Tonkins
Sereen Gmorgan Murray's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2017 | FDA 483 | Robert Donald Harvey - Form 483, 2017-03-24 |
September, 2019 | FDA 483 | Laura Mulloy, D.O. - Form 483, 2019-09-11 |
February, 2018 | FDA 483 | Wellstar Atlanta Medical Center IRB#1 - Form 483, 2018-02-15 |
November, 2021 | FDA 483 | Daniel C. Tarquinio, DO - Form 483, 2021-11-05 |
May, 2021 | EIR | PPD, Inc., part of Thermo Fisher Scientific - EIR, 2021-05-21 |
November, 2017 | FDA 483 | O'Barr, Thomas MD - Form 483, 2017-11-30 |
October, 2019 | FDA 483 | Kennedy, Philip R. - Form 483, 2019-10-16 |
March, 2016 | EIR | Phoebe Putney Mem Hosp Irc - EIR, 2016-03-03 |
October, 2018 | FDA 483 | Naomi Akita, MD - Form 483, 2018-10-11 |
August, 2016 | EIR | Martin Throne MD - EIR, 2016-08-05 |
October, 2016 | EIR | Sagar Lonial, M.D. - EIR, 2016-10-28 |
April, 2018 | FDA 483 | Theresa Lawrence Ford - Form 483, 2018-04-03 |
March, 2018 | FDA 483 | Georgia STE DEPT Human Resources IRB#1 - Form 483, 2018-03-08 |
April, 2016 | FDA 483 | J. David Lentz III, M.D. - Form 483, 2016-04-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more